CNS involvement and treatment with interferon-α are independent prognostic factors in Erdheim-Chester disease: a multicenter survival analysis of 53 patients.

Blood 2011 Mar 14;117(10):2778-82. Epub 2011 Jan 14.

Department of Internal Medicine and French Reference Center for Rare Autoimmune and Systemic Diseases, AP-HP, Pitié-Salpêtrière Hôpital, Paris, France.

Erdheim-Chester disease (ECD) is a rare form of non-Langerhans histiocytosis, with noncodified therapeutic management and high mortality. No treatment has yet been shown to improve survival in these patients. We conducted a multicenter prospective observational cohort study to assess whether extraskeletal manifestations and interferon-α treatment would influence survival in a large cohort of ECD patients. To achieve this goal, we thoroughly analyzed the clinical presentation of 53 patients with biopsy-proven ECD, and we performed a survival analysis using Cox proportional hazard model. Fifty-three patients (39 men and 14 women) with biopsy-proven ECD were followed up between November 1981 and November 2010. Forty-six patients (87%) received interferon-α and/or PEGylated interferon-α. Multivariate survival analysis using Cox proportional hazard model revealed that central nervous system involvement was an independent predictor of death (hazard ratio = 2.51; 95% confidence interval, 1.28-5.52; P = .006) in our cohort. Conversely, treatment with interferon-α was identified as an independent predictor of survival (hazard ratio = 0.32; 95% confidence interval, 0.14-0.70; P = .006). Although definitive confirmation would require a randomized controlled trial, these results suggest that interferon-α improves survival in ECD patients. This may be seen as a significant advance, as it is the first time a treatment is shown to improve survival in this multisystemic disease with high mortality.

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2010-06-294108DOI Listing
March 2011
45 Reads

Publication Analysis

Top Keywords

survival analysis
12
confidence interval
8
erdheim-chester disease
8
hazard ratio
8
biopsy-proven ecd
8
survival
8
cox proportional
8
independent predictor
8
treatment improve
8
improve survival
8
95% confidence
8
hazard model
8
proportional hazard
8
high mortality
8
treatment interferon-α
8
analysis cox
8
ecd patients
8
patients
7
interferon-α
6
ecd
5

Similar Publications